Asako Nogami

Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial

Masato Yoneda, Yasushi Honda, Yuji Ogawa et al. · BMJ Open Diabetes Research & Care · 2021 · 97 citations · Full text

Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan

Masato Yoneda, Takuma Yamamoto, Yasushi Honda et al. · Journal of Gastroenterology · 2021 · 93 citations · Full text

Numerical simulation of equiaxed grain formation in weld solidification

Takafumi Koseki, Hiroshige Inoue, Y. Fukuda et al. · Science and Technology of Advanced Materials · 2003 · 60 citations · Full text

Materials Science, Engineering, Weld Solidification +14

Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease

Michihiro Iwaki, Takaomi Kessoku, Anna Ozaki et al. · Journal of Gastroenterology and Hepatology · 2021 · 39 citations

Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial

Masato Yoneda, Takashi Kobayashi, Yasushi Honda et al. · Hepatology Communications · 2022 · 36 citations · Full text